Regeneron Pharmaceuticals Inc (REGN)

Quick ratio

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cash US$ in thousands 2,506,400 1,995,800 3,090,200 2,488,200 2,011,800 1,920,700 2,602,000 2,730,000 2,152,300 1,937,200 3,916,300 3,105,900 3,491,300 3,395,100 3,345,700 2,885,600 3,432,400 2,072,200 1,437,900 2,193,700
Short-term investments US$ in thousands 5,937,200 5,473,800 5,259,200 6,524,300 7,784,700 7,888,300 7,917,500 8,114,800 7,761,300 6,990,500 5,043,400 4,636,400 3,530,400 4,171,300 3,704,900 2,809,100 2,355,200 1,838,600 2,065,900 1,393,300
Receivables US$ in thousands 5,687,100 5,610,000 5,561,000 6,211,900 6,107,100 5,717,100 5,222,200 5,667,300 5,584,500 5,121,300 5,118,600 5,328,700 5,548,300 5,161,400 4,839,000 6,036,500 5,452,000 6,998,600 4,173,000 4,114,700
Total current liabilities US$ in thousands 4,425,100 3,667,000 3,566,600 3,944,300 3,661,000 3,508,600 3,580,900 3,423,400 3,598,600 3,104,400 3,100,100 3,141,300 2,879,200 3,033,900 3,007,600 3,932,500 3,714,800 3,732,400 3,217,800 2,806,800
Quick ratio 3.19 3.57 3.90 3.86 4.34 4.43 4.40 4.82 4.31 4.53 4.54 4.16 4.37 4.20 3.95 2.98 3.03 2.92 2.39 2.74

September 30, 2025 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($2,506,400K + $5,937,200K + $5,687,100K) ÷ $4,425,100K
= 3.19

Peer comparison

Sep 30, 2025

Company name
Symbol
Quick ratio
Regeneron Pharmaceuticals Inc
REGN
3.19
Arrowhead Pharmaceuticals Inc
ARWR
4.74
Biomarin Pharmaceutical Inc
BMRN
2.84

See also:

Regeneron Pharmaceuticals Inc Quick Ratio (Quarterly Data)